Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Geographic Atrophy (GA)”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Not applicableLooking for participantsNCT07144137
What this trial is testing

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics 75
Testing effectiveness (Phase 2)Study completedNCT02515942
What this trial is testing

CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Alcon Research 114
Early research (Phase 1)Study completedNCT00973011
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Genentech, Inc. 18
Testing effectiveness (Phase 2)WithdrawnNCT03446144
What this trial is testing

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge Related Macular Degeneration
Ionis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00695318
What this trial is testing

Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
Alimera Sciences 17
Testing effectiveness (Phase 2)UnknownNCT00485394
What this trial is testing

The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)

Who this might be right for
Age-Related Macular Degeneration
Othera Pharmaceuticals 198
Testing effectiveness (Phase 2)Study completedNCT04465955
What this trial is testing

NGM621 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy
NGM Biopharmaceuticals, Inc 320
Testing effectiveness (Phase 2)Looking for participantsNCT06659445
What this trial is testing

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

Who this might be right for
Geographic Atrophy (GA)Age - Related Macular Degeneration (AMD)
ONL Therapeutics 324
Testing effectiveness (Phase 2)Study completedNCT02613572
What this trial is testing

Alpha Lipoic Acid in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
University of Pennsylvania 68
Early research (Phase 1)Study completedNCT03295877
What this trial is testing

Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic Atrophy
Genentech, Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT07029945
What this trial is testing

The Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Biojiva LLC 152
Large-scale testing (Phase 3)Looking for participantsNCT06635148
What this trial is testing

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyMacular Degeneration
Janssen Research & Development, LLC 274
Testing effectiveness (Phase 2)Ended earlyNCT03846193
What this trial is testing

FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD

Who this might be right for
Dry Age-related Macular DegenerationMacular DegenerationRetinal Disease+4 more
Gyroscope Therapeutics Limited 56
Testing effectiveness (Phase 2)Ended earlyNCT01603043
What this trial is testing

A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic Atrophy
Alcon Research 10
Large-scale testing (Phase 3)Active Not RecruitingNCT06373731
What this trial is testing

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Who this might be right for
Age Related Macular Degeneration (ARMD)
Stealth BioTherapeutics Inc. 313
Testing effectiveness (Phase 2)Study completedNCT03891875
What this trial is testing

ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA

Who this might be right for
Age-related Macular Degeneration
Stealth BioTherapeutics Inc. 176
Testing effectiveness (Phase 2)Study completedNCT02503332
What this trial is testing

Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Apellis Pharmaceuticals, Inc. 246
Testing effectiveness (Phase 2)Study completedNCT01527500
What this trial is testing

Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge-related Macular Degeneration
Novartis Pharmaceuticals 158
Early research (Phase 1)Study completedNCT03777332
What this trial is testing

Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Apellis Pharmaceuticals, Inc. 19
Testing effectiveness (Phase 2)Ended earlyNCT05019521
What this trial is testing

Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Alexion Pharmaceuticals, Inc. 365
Next Page